Business

Novo Nordisk Raises Forecasts on New Obesity Drug

Published

on



Aug.05 — Lars Fruergaard Jorgensen, Novo Nordisk chief executive officer, discusses first half earnings results. The Danish …

source

Leave a Reply

Your email address will not be published. Required fields are marked *

Trending

Exit mobile version